AS03(B)-Adjuvanted H5N1 Influenza Vaccine in Children 6 Months Through 17 Years of Age: A Phase 2/3 Randomized, Placebo-Controlled, Observer-Blinded Trial

Background. This phase 2/3, randomized, placebo-controlled, observer-blinded study assessed the immunogenicity, reactogenicity, and safety of an inactivated, split-virion H5N1 influenza vaccine (A/Indonesia/5/2005) in children aged 6 months through 17 years. Methods. Children received 2 influenza va...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosalaraksa, Pope, Jeanfreau, Robert, Frenette, Louise, Drame, Mamadou, Madariaga, Miguel, Innis, Bruce L., Godeaux, Olivier, Izurieta, Patricia, Vaughn, David W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319481/
https://www.ncbi.nlm.nih.gov/pubmed/25293368
http://dx.doi.org/10.1093/infdis/jiu548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4319481/
https://www.ncbi.nlm.nih.gov/pubmed/25293368
http://dx.doi.org/10.1093/infdis/jiu548

Ejemplares similares